Omega-3 Fish Oil: EPA vs DHA, the Right Dose, and Why Quality Matters

Why Omega-3s Are Clinically Significant

The omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are among the most researched nutrients in clinical medicine, with over 40,000 published studies. Unlike most supplements, high-dose pharmaceutical omega-3s (Vascepa/icosapentaenoic acid) have received FDA approval for cardiovascular risk reduction.

The clinical evidence covers:

• Triglyceride reduction: EPA+DHA at 3-4g/day reduces triglycerides by 25-30% (well-established, recognized by the American Heart Association)
• Cardiovascular mortality: The REDUCE-IT trial (8,000 patients) found high-dose EPA (4g/day Vascepa) reduced major cardiovascular events by 25% vs placebo in high-risk patients
• Inflammation: Omega-3s are converted to resolvins and protectins — specialized pro-resolving mediators that actively resolve inflammation
• Depression: A 2019 meta-analysis found EPA-predominant omega-3s significantly reduced depression scores, with effects comparable to antidepressants in mild-to-moderate depression
• Brain health: DHA is structurally essential for the neuronal membrane — 60% of brain dry weight is fat, and a third of that is DHA

EPA vs DHA: Different Roles

EPA (Eicosapentaenoic Acid) — The Anti-Inflammatory

• Competes with arachidonic acid for COX and LOX enzymes (primary mechanism of inflammation reduction)
• Reduces production of pro-inflammatory eicosanoids
• More potent than DHA for cardiovascular protection, triglyceride reduction, and depression
• REDUCE-IT trial used pure EPA (Vascepa) — the most compelling omega-3 cardiovascular data to date

DHA (Docosahexaenoic Acid) — The Structural Architect

• Critical for brain and retina structure; can't be substituted
• Essential during fetal development and infancy (why pregnant women are advised to take DHA)
• Supports neuronal membrane fluidity and synaptic function
• Important for children's cognitive development
• Less anti-inflammatory than EPA per gram

Bottom line: For most adults, a 2:1 EPA:DHA ratio is supported by research for general anti-inflammatory and cardiovascular benefits. Those with depression may benefit from predominantly EPA (72%+ EPA). Pregnant women and children should prioritize DHA.

The Omega-3 Index: Your Most Important Biomarker

The omega-3 index is the percentage of EPA+DHA as a percentage of total red blood cell fatty acids. It's one of the strongest predictors of cardiovascular risk:

The average American omega-3 index is around 4-5%. Japanese populations, who consume significant amounts of fatty fish, regularly test at 8-11% — and have dramatically lower rates of cardiovascular disease.

Testing your omega-3 index (available through OmegaQuant and some comprehensive lab panels) gives you a direct measure of whether your supplementation is actually working.

Getting the Dose Right

Most studies showing meaningful clinical effects use 2-4g of combined EPA+DHA per day. Standard fish oil capsules typically contain 1g fish oil with 300mg EPA+DHA — meaning you'd need 7-13 capsules for a therapeutic dose.

This is why high-concentration fish oil or triglyceride-form omega-3s are preferred:

Ethyl Ester (EE) form: Cheaper, widely available, lower bioavailability, more prone to oxidation. Most mass-market fish oil.

Triglyceride (rTG) form: More expensive, 24-71% better bioavailability, more stable. The form found in whole fish; preferred in well-designed clinical trials.

Phospholipid form (krill oil): Excellent bioavailability, but typically lower EPA+DHA per capsule. Useful for those with GI sensitivity to fish oil.

Dosing by Goal

Quality Red Flags

Fish oil is one of the most adulterated and oxidized supplements on the market. Watch for:

Rancidity: Oxidized omega-3s are not only ineffective — they may be actively harmful, increasing oxidative stress. Fresh fish oil should have no noticeable fishy smell. Significant "fishy burps" often indicate oxidized oil.

Third-party testing: Look for IFOS (International Fish Oil Standards) certification. Consumer Lab regularly finds 30-50% of tested fish oils have less EPA+DHA than claimed.

Form: Check whether the product specifies triglyceride form. Ethyl ester is cheaper but significantly less bioavailable.

Source: Wild-caught small fish (sardines, anchovies, mackerel) have less bioaccumulation of heavy metals than large predatory fish.

How ONES AI Personalizes Your Formula

Every ONES AI formula is built around your data — not population averages, generic recommendations, or marketing copy.

When your lab results, health history, and symptom picture suggest a need in the area discussed above, our AI health practitioner will:

• Explain which compounds the clinical evidence supports for your situation
• Select ingredients and doses from our curated catalog of 70+ clinical-grade ingredients
• Build a formula that fits your daily capsule budget and avoids interactions with your current medications or supplements
• Provide a clear rationale for every ingredient included — and every ingredient left out

No guessing. No one-size-fits-all blends. A formula that reflects your actual physiology.

Start your personalized assessment →

These statements have not been evaluated by the Food and Drug Administration. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement regimen.

---

References

1. Bhatt DL, Steg PG, Miller M, et al. (REDUCE-IT Investigators). "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia." New England Journal of Medicine. 2019 Jan 3;380(1):11–22. PMID: 30415628

→ 8,179 patients on statins with elevated triglycerides. EPA 4g/day (icosapent ethyl) vs. placebo. Primary endpoint occurred in 17.2% vs. 22.0% (HR 0.75; 25% relative risk reduction, p<0.001) over median 4.9 years.

1. Siscovick DS, Barringer TA, Fretts AM, et al. "Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association." Circulation. 2017;135(15):e867–e884. PMID: 28289069

1. Sublette ME, Ellis SP, Geant AL, Mann JJ. "Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression." Journal of Clinical Psychiatry. 2011;72(12):1577–84. PMID: 21939614

Note: The REDUCE-IT trial used a pharmaceutical-grade preparation of pure EPA (icosapent ethyl), not standard fish oil. Results may not fully generalize to over-the-counter omega-3 supplements. This is not medical advice.